Pre-clinical validation of a humanized anti-EGFR variant III chimeric antigen receptor and phase I trial of CART-EGFRvIII in glioblastoma

Detalles Bibliográficos
Autores principales: Johnson, Laura A, Scholler, John, Ohkuri, Takayuki, Kosaka, Akemi, Patel, Prachi R, McGettigan, Shannon E, Nace, Arben, Thekkat, Pramod, Loew, Andreas, Chen, Taylor J, Fraietta, Joseph A, Posey, Avery D, Boesteanu, Alina C, Cogdill, Alexandria P, Engels, Boris, Singh, Reshma, Ezell, Tucker R, Idamakanti, Neeraja, Plesa, Gabriela, Seykora, John, Okada, Hideho, June, Carl, Brogdon, Jennifer, Maus, Marcela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288312/
https://www.ncbi.nlm.nih.gov/pubmed/25746013
http://dx.doi.org/10.1186/2051-1426-2-S3-O1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288312/
https://www.ncbi.nlm.nih.gov/pubmed/25746013
http://dx.doi.org/10.1186/2051-1426-2-S3-O1

Ejemplares similares